BKYI stock news · BIO-key International
Get alerts for BKYI
Follow BIO-key International (BKYI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BKYI12 tech stocks are changing a lot during Friday's trading.
NeutralBIO-key International shares rose 32.1%. The story reports no new business results or company news to show what the move means for the company.
12 tech stocks are changing a lot before the market opens on Friday.
NeutralBIO-key International shares rose 12.6% in Friday's pre-market session. The article gives no business news to explain the move, so it does not change the company's outlook.
12 tech stocks are changing a lot before the market opens on Thursday.
NeutralBIO-key International's shares rose 26.7% to $2.66 in Thursday's pre-market session. The story gives no company news showing a change in its business prospects.
12 tech stocks changed a lot during Thursday's after-hours trading.
NeutralThe story says BIO-key International shares rose 4.39% to $3.08. It gives no company news, so this move alone does not change our read of its business.
12 tech stocks are changing a lot before the market opens on Wednesday.
NeutralBIO-key International shares fell 11.39% before Wednesday's open, but the article gives no company news behind the move. It does not change the company's business outlook.
12 tech stocks are changing a lot before the market opens on Tuesday.
NeutralBIO-key shares rose in pre-market trading, but the article reports no company news behind the move. It does not change the business outlook.
Here are 10 tech stocks that are changing in value before the market opens on Friday.
NeutralThe report says BIO-key International shares fell 4.33% in pre-market trading. It gives no company news to explain the move, so the business outlook is unchanged.
BIO-key International, Inc. has signed important new agreements with Streeterville Capital, LLC.
NeutralBIO-key paid off its original lender note by issuing 247,805 shares. The debt relief is balanced by the smaller ownership slice, so the filing does not change the outlook.
12 tech stocks are changing a lot before the market opens on Friday.
NeutralBIO-key International shares fell 9% before Friday's open. The report gives no business reason for the move, so it does not change the company's outlook.
12 tech stocks are changing a lot during Thursday's trading.
NeutralThe report says BIO-key shares fell 18% during Thursday's session. It gives no business news, so it does not change what we know about the company.
12 tech stocks are changing a lot before the market opens on Wednesday.
NeutralBIO-key International shares fell 10.23% before Wednesday's market open. The report gives no company update to change its business outlook.
12 tech stocks are changing a lot during Tuesday's trading.
NeutralBIO-key shares rose 68.5% in Tuesday trading, but the article gives no company news explaining the move. The report alone does not change its business outlook.
12 tech stocks are changing a lot before the market opens on Tuesday.
NeutralBIO-key International's shares rose about 56% in pre-market trading. The article gives no company news or results, so it does not change the outlook for its business.
12 tech stocks are changing a lot before the market opens on Thursday.
NeutralBIO-key International was shown lower in pre-market but without company updates, so this price move does not change how we read BIO-key.
BIO-key (BKYI) stock dropped 13% after the market closed: here's the latest news.
NeutralBIO-key's Passkey won FIDO certification, boosting product credibility. Without immediate sales or customer wins, this news does not change BIO-key's outlook.
12 tech stocks changed a lot in Friday's after-hours trading.
NeutralBIO-key International rose 8.1% to $2.68 in the list, but the article gives no operational or financial detail to change the company view.
Q2 2026 financial results released by BIO-key International: Complete earnings call transcript available.
NeutralBIO-key International's Q2 2026 earnings report shows a notable improvement in financial metrics, including a significant reduction in net loss and an increase in revenue. The company's strategic initiatives and partnerships in the EMEA region, along with a strong gross margin, suggest a positive outlook for future growth, making this news actionable for investors.
BIO-key International, Inc. discloses operational outcomes and financial status (BKYI).
NeutralBIO-key International, Inc. has filed a Form 8-K detailing its results of operations and financial condition, which is expected to provide investors with crucial insights into the company's performance and future outlook, potentially driving positive market sentiment.
BioKey (Cayman), Inc. announces a transition in its certifying accountant.
NeutralBioKey (Cayman), Inc. has filed a Form 8-K indicating a change in its certifying accountant, which is a critical disclosure that may raise questions about the company's financial oversight and could influence investor sentiment.